Reading through their collaborations, look at the dates of the initiated research...
Biodefense Collaborations
BARDA
In 2011, Chimerix initiated a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop TEMBEXA as a medical countermeasure to treat smallpox outbreaks due to a bioterror event or accidental release. In June 2021, TEMBEXA was approved by the U.S. FDA. Read the announcement
Reading through their collaborations, look at the dates of the initiated research...
Biodefense Collaborations BARDA In 2011, Chimerix initiated a partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop TEMBEXA as a medical countermeasure to treat smallpox outbreaks due to a bioterror event or accidental release. In June 2021, TEMBEXA was approved by the U.S. FDA. Read the announcement
2011 huh? another Obummer era project.